Full text is available at the source.
Abstract
The prevalence of Long COVID in patients with autoimmune rheumatic diseases (AIRDs) remains largely unknown.
- There is limited understanding of the factors that may be associated with Long COVID in this population.
- Research on Long COVID specifically within AIRDs is still in its early stages.
- Preliminary findings suggest that AIRDs could influence the risk of developing Long COVID.
Simplified
Long Covid